GILEAD SCIENCES, INC. — Director's Dealing 2015

Feb 4, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-02-02

Reporting Person: Whitley Richard James (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-02	Common Stock	M	5000	$26.9900	Acquired	20641	Direct
2015-02-02	Common Stock	S	2800	$105.1596	Disposed	17841	Direct
2015-02-02	Common Stock	S	1400	$106.0421	Disposed	16441	Direct
2015-02-02	Common Stock	S	800	$106.8150	Disposed	15641	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-02	Non-Qualified Stock Option (Right to Buy)	$26.9900	M	5000	Disposed	2018-07-30	Common Stock (5000)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: Options are 50% vested on the first anniversary of the date of grant and 100% vested on the second anniversary of the date of grant.

F3: Sale prices reported for the transactions reported here range from $104.63 to $105.53. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $105.69 to $106.39. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F5: Sale prices reported for the transactions reported here range from $106.70 to $107.01. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.